A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry

por Blommestein, Hedwig M., Franken, Margreet G., Uyl-de Groot, Carin A.
Publicado 2015

Costs of Newly Funded Proton Therapy Using Time-Driven Activity-Based Costing in The Netherlands

por Chen, Yi Hsuan, Blommestein, Hedwig M., Klazenga, Reinder, Uyl-de Groot, Carin, van Vulpen, Marco
Publicado 2023

A Systematic Review of Cost-Effectiveness Analyses of Novel Agents in the Treatment of Multiple Myeloma

por Seefat, Maarten R., Cucchi, David G. J., Dirven, Stijn, Groen, Kaz, Zweegman, Sonja, Blommestein, Hedwig M.
Publicado 2021

Medical Resource Use and Medical Costs for Radiotherapy-Related Adverse Effects: A Systematic Review

por Chen, Yi Hsuan, Molenaar, Dominique, Uyl-de Groot, Carin A., van Vulpen, Marco, Blommestein, Hedwig M.
Publicado 2022

Cost-Effectiveness Analysis of MammaPrint(®) to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer

por Luyendijk, Marianne, Jager, Agnes, Buijs, Sanne M., Siesling, Sabine, Groot, Carin A. Uyl-de, Blommestein, Hedwig M.
Publicado 2023

Efficacy of first-line treatments for multiple myeloma patients not eligible for stem cell transplantation: a network meta-analysis

por Blommestein, Hedwig M., van Beurden-Tan, Chrissy H.Y., Franken, Margreet G., Uyl-de Groot, Carin A., Sonneveld, Pieter, Zweegman, Sonja
Publicado 2019

Lenalidomide for the Treatment of Low- or Intermediate-1-Risk Myelodysplastic Syndromes Associated with Deletion 5q Cytogenetic Abnormality: An Evidence Review of the NICE Submissi...

por Blommestein, Hedwig M., Armstrong, Nigel, Ryder, Steve, Deshpande, Sohan, Worthy, Gill, Noake, Caro, Riemsma, Rob, Kleijnen, Jos, Severens, Johan L., Al, Maiwenn J.
Publicado 2015

Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE...

por Büyükkaramikli, Nasuh C., Blommestein, Hedwig M., Riemsma, Rob, Armstrong, Nigel, Clay, Fiona. J., Ross, Janine, Worthy, Gill, Severens, Johan, Kleijnen, Jos, Al, Maiwenn J.
Publicado 2017

Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients’ Needs?

por Jongbloed, Elisabeth M, Blommestein, Hedwig M, van Schoubroeck, Hannah M, Martens, John W M, Wilting, Saskia M, Uyl-de Groot, Carin A, Jager, Agnes
Publicado 2023

Long-term Outcomes in Patients With Multiple Myeloma: A Retrospective Analysis of the Dutch Population-based HAematological Registry for Observational Studies (PHAROS)

por Verelst, Silvia G.R., Blommestein, Hedwig M., De Groot, Saskia, Gonzalez-McQuire, Sebastian, DeCosta, Lucy, de Raad, Johan B., Uyl-de Groot, Carin A., Sonneveld, Pieter
Publicado 2018

Cost-effectiveness of Novel Treatment Sequences for Transplant-Ineligible Patients With Multiple Myeloma

por Blommestein, Hedwig M., Franken, Margreet G., van Beurden-Tan, Chrissy H. Y., Blijlevens, Nicole M. A., Huijgens, Peter C., Sonneveld, Pieter, Uyl-de Groot, Carin A., Zweegman, Sonja
Publicado 2021

Changes in survival in de novo metastatic cancer in an era of new medicines

por Luyendijk, Marianne, Visser, Otto, Blommestein, Hedwig M, de Hingh, Ignace H J T, Hoebers, Frank J P, Jager, Agnes, Sonke, Gabe S, de Vries, Elisabeth G E, Uyl-de Groot, Carin A, Siesling, Sabine
Publicado 2023